Atlas Trials

IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

Clinical trial NCT07478315 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07478315
Sponsor
Charles LeMoyne Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2026-03-15
Primary completion
2026-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.